Dansky Ullmann Claudio 4
4 · Context Therapeutics Inc. · Filed Aug 1, 2024
Insider Transaction Report
Form 4
Dansky Ullmann Claudio
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2024-08-01+202,170→ 202,170 totalExercise: $2.23Exp: 2034-07-31→ Common Stock (202,170 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on August 1, 2025, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer.